The Presidential Task Force On COVID-19 said it is validating three out of numerous claims of COVID-19 local cure.
Boss Mustapha, the Secretary to the Government of the Federation (SGF) and Chairman of Presidential Task Force (PTF) on COVID-19 disclosed this on Wednesday during the daily briefing of the Task Force.
“As a measure of the importance attached to research and development of local capacity for finding a cure to the COVID-19, the Federal Ministry of Health held a virtual meeting with a number of researchers and scientists with claims to cure for COVID 19 and out of the numerous claimants, three were found to deserve further investigation and have been forwarded to the relevant authorities for appropriate review.
“Similarly, efforts are being made by the Federal Ministry of Science and Technology to subject a good number of locally manufactured COVID 19 equipment to verification and subsequent certification.
“Countries in the region need to progressively increase their capacity to detect cases, not just to know the extent of the outbreak, but also to identify and initiate care for people most at risk. They also need to expand capacity to mitigate the implications of widespread community transmission of COVID-19.
“Above all, more research to determine the underlying factors for the current trend in the pandemic in Africa is needed. In addition to pursuing this line of thought, the occurrences in Kano and some other cities have given us cause to launch our research initiatives using existing structures and systems in a manner that will build a legacy and also prepare Nigeria for any future pandemic.
He added that the Central Bank of Nigeria had promised to provide needed support for the success of the research. He also urged citizen to avoid self medication in treating the respiratory illness.
“The PTF is happy to note that the Central Bank of Nigeria has indicated the willingness to support research efforts. This is, therefore, a call on our researchers and scientists to take up the challenge.
“The use of Hydroxy-chloroquine was discouraged because it had not been certified for use in treating COVID-19. We have read in the media about the side effects of the use of this drug from COVID-19 patients that survived as well as those who took it outside clinical supervision.
“The World Health Organization (WHO), has temporarily suspended all clinical trials of hydroxychloroquine as a potential treatment for COVID-19. This advice was informed by a study which identified that the use of hydroxy-chloroquine, either alone or with other drugs, has been responsible for a high number of deaths.
“This precautionary measure by the WHO underscores the importance of not only seeking expert medical advice but also ensuring that all claims to treatment by scientists and researchers, whether conventional or traditional should be subjected to scientific certification protocols by NAFDAC and other relevant institutions so as to guarantee the efficacy of the discovery,” he said.
- Breaking: Ohanaeze President General, George Obiozor, confirmed dead - December 28, 2022
- US to support NDLEA on improved intelligence gathering capacity - December 27, 2022
- Why diversified HIV/AIDS prevention tools matter for women - December 26, 2022
